期刊文献+

紫杉醇抑制前列腺癌增殖的体内实验研究 被引量:1

Inhibition of Taxol on proliferation of human prostate cancer cells in vivo
原文传递
导出
摘要 目的探讨紫杉醇对人前列腺癌细胞PC-3增殖的体内抑制作用。方法建立体内绿色荧光蛋白(GFP)标记的人雄激素非依赖性前列腺癌细胞PC-3裸鼠原位移植瘤模型,观察紫杉醇对裸鼠前列腺癌原位移植瘤的体积、重量的影响。结果裸鼠模型体内实验显示,与对照组(100μL生理盐水)相比,紫杉醇处理组(0.5 mg/kg)在给药第18天后能显著抑制前列腺肿瘤的体积(P<0.05);紫杉醇处理组在抑制前列腺肿瘤重量方面与对照组相比亦有明显抑制作用(P<0.05)。与对照组相比G31P处理组VEGF(P<0.05)的表达差异具有统计学意义(免疫组化法)。结论紫杉醇在体内实验中能明显抑制人雄激素非依赖性前列腺癌细胞系PC-3的增殖。 Objective To investigate the inhibition of Taxol on the proliferation of prostate cancer PC-3 cell in vivo.Methods The effect of Taxol on the volume and weight of human prostate tumor were observed in nude mice by building a human androgen-independent prostate cancer PC-3( GFP-labeled) orthotopic transplantation tumor cells model. Results Compared with control group,the prostate tumor volume of Taxol treatment group was inhibited significantly 18 days after taxol administration( P 〈 0. 05); significant inhibition on prostate tumor weight in Taxol treatment group( P 〈 0. 05) was observed; VEGF expression in Taxol treated group was significantly reduced( P 〈0. 05) according to immunohistochemistry. Conclusion Taxol can inhibit the proliferation of the PC-3 cell of prostate cancer in vivo.
出处 《中国微生态学杂志》 CAS CSCD 2014年第10期1155-1157,共3页 Chinese Journal of Microecology
关键词 紫杉醇 前列腺癌 血管内皮生长因子 Taxol Prostate cancer Vascular endothelial growth factor
  • 相关文献

参考文献6

二级参考文献55

  • 1汪万英,何杰,张世馥,姚敏,唐素兰.金葡菌及其L型感染荷瘤小鼠的实验研究[J].中国微生态学杂志,1996,8(5):38-39. 被引量:21
  • 2RICHARD C, KIM G, KOIKAWA Y ,et al. Androgens modulate the balance between VEGF and angiopoietin expression in prostate epithelial and smooth muscle cells [ J ]. Prostate,2002,50 ( 2 ) : 83-91.
  • 3BORRE M, NERSTROM B, OVERGASARD J, et al. Association between expression of vascular endothelial growth factor(VEGF), VEGF-expressiing neurcendocrine differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting[J]. Clin Cancer Res,2000,6(5) :1882-1890.
  • 4ERRARA N, DAVIS-SMYTH T. The biology of vascular endothelial growth factor[ J ]. Endocr Rev, 1997,18 ( 1 ) :4-25.
  • 5MASOOD R,CAI J,ZHENG T,et al. Vascular endothelial growth factor (VEGF) is an antocfine growth factor for VEGF receptor-positive hu-man tumors[ J]. Blood ,2001,98 (6) : 1904-1913.
  • 6LATIL A. VEGF overexpression in clinically localized prostate tumors and neurophilin-1 overexpression in metastatic forms[ J]. Int J Cancer, 2000,89(2) :167-171.
  • 7BROWN L,BRASE B,JACKMAN R,et al. Expression of vascular permeability factor (vascular endothelial groth factor) and itsreceptor inbreas cancer[J]. Am J Path,1995,146(2) :357-360.
  • 8ZLOTNIC A,YOSHIE O. Chemokines:a new classification system and their role in immunity[J].Immunity,2000,(02):121-127.doi:10.1016/S1074-7613(00)80165-X.
  • 9STRIETER R M,BURDICKM D,GOMPERT B N. CXC chemokines in angiogenesis[J].Cytokine & Growth Factor Reviews,2005,(06):593-609.
  • 10VICARI AP,CAUX C. Chemokines in cancer[J].Cytok & Growth Factor Rev,2002,(02):143-154.

共引文献20

同被引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部